Tufton Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-11,858
Closed -$40K 99
2015
Q4
$40K Sell
11,858
-65,225
-85% -$220K 0.01% 96
2015
Q3
$411K Buy
+77,083
New +$411K 0.09% 86